PT Medikaloka Hermina Tbk Financials

Market Capitalization Rp22.633 Trillion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	40.72
Forward PE	30.86
Price to Sales TTM	Rp3.44
Price to Book MRQ	Rp5.17
Enterprise to Revenue	4.03
Enterprise to EBITDA	15.29

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	8.46%
Operating Margin	14.86%
Return on Assets TTM	6.99%
Return on Equity TTM	13.28%

Income Statement

Revenue TTM	Rp6,580,738,195,456
Revenue per Share TTM	Rp446.06
Quarterly Revenue Growth	9.40%
Gross Profit TTM	Rp2,274,561,097,728
EBITDA	Rp1,344,133,000,000
Net Income to Common TTM	Rp556,665,995,264
Diluted EPS TTM	Rp37.33
Quarterly Earnings Growth YoY	-14.70%

Balance Sheet

Total Cash MRQ	Rp672,303,022,080
Total Cash per Share MRQ	Rp45.15
Total Debt MRQ	Rp
Total Debt to Equity MRQ	52.34
Current Ratio MRQ	1.22
Book Value per Share MRQ	Rp294.26

Cash Flow

Operating Cash Flow TTM	Rp1,311,995,985,920
Levered Free Cash Flow TTM	Rp-1,096,814,886,912

HEAL Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	14,890,000,384
Float Shares	6,299,227,192
Avg 10 Volume	19,550,800
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	45.80%
% Held by Institutions	5.92%

Stock Price Summary

Beta	0.48
Fifty Two Week Low	Rp1060.00
Fifty Two Week High	Rp1710.00
Fifty Two Week Change	12.91%
Day 50 MA	Rp1499.40
Day 200 MA	Rp1384.60

Dividends and Splits

Forward Annual Dividend Rate	Rp34.00
Forward Annual Dividend Yield	2.25%
Trailing Annual Dividend Rate	Rp8.50
Trailing Annual Dividend Yield	0.56%
Payout Ratio	22.78%
Dividend Date
Ex Dividend Date	2024-05-22
Last Split Factor
Last Split Date	2021-07-30